Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Haruka Nishimuta, Kimihiko Sato, Takao Watanabe & Masashi Yabuki. (2019) Time-dependent inhibition (TDI) of CYP1A2 by a CYP3A4-mediated reactive metabolite: proposal for a novel mechanism of irreversible TDI by a non-suicide substrate. Xenobiotica 49:6, pages 636-645.
Read now
Read now
Wenqin Liu, Jian Shi, Lijun Zhu, Lingna Dong, Feifei Luo, Min Zhao, Ying Wang, Ming Hu, Linlin Lu & Zhongqiu Liu. (2015) Reductive metabolism of oxymatrine is catalyzed by microsomal CYP3A4. Drug Design, Development and Therapy 9, pages 5771-5783.
Read now
Read now
Jia-Xuan Qiu, Zhi-Wei Zhou, Zhi-Xu He, Xueji Zhang, Shu-Feng Zhou & Shengrong Zhu. (2015) Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies. Drug Design, Development and Therapy 9, pages 841-866.
Read now
Read now
Zhi-Xu He, Xiao-Wu Chen, Zhi-Wei Zhou & Shu-Feng Zhou. (2015) Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine. Drug Metabolism Reviews 47:4, pages 470-519.
Read now
Read now
Junhui Su, Cui Chang, Qi Xiang, Zhi-Wei Zhou, Rong Luo, Lun Yang, Zhi-Xu He, Hongtu Yang, Jianan Li, Yu Bei, Jinmei Xu, Minjing Zhang, Qihao Zhang, Zhijian Su, Yadong Huang, Jiyan Pang & Shu-Feng Zhou. (2014) Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study. Drug Design, Development and Therapy 8, pages 2555-2602.
Read now
Read now
David M Stresser, Jialin Mao, Jane R Kenny, Barry C Jones & Kenneth Grime. (2014) Exploring concepts of in vitro time-dependent CYP inhibition assays. Expert Opinion on Drug Metabolism & Toxicology 10:2, pages 157-174.
Read now
Read now
Li-Ping Yang, Zhi-Wei Zhou, Xiao-Wu Chen, Chun Guang Li, Kevin B. Sneed, Jun Liang & Shu-Feng Zhou. (2012) Computational and in vitro studies on the inhibitory effects of herbal compounds on human cytochrome P450 1A2. Xenobiotica 42:3, pages 238-255.
Read now
Read now
Shu-Feng Zhou, Bo Wang, Li-Ping Yang & Jun-Ping Liu. (2010) Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metabolism Reviews 42:2, pages 268-354.
Read now
Read now
Articles from other publishers (20)
Sabrina Orzetti & Paolo Baldo. (2023) Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports. International Journal of Molecular Sciences 24:21, pages 15976.
Crossref
Crossref
Dominic D. Martinelli. (2023) Machine learning for metabolomics research in drug discovery. Intelligence-Based Medicine 8, pages 100101.
Crossref
Crossref
Jing Ning, Zhenhao Tian, Jiayue Wang, Bo Wang, Xiangge Tian, Zhenlong Yu, Xiaokui Huo, Lei Feng, Jingnan Cui, Tony D. James & Xiaochi Ma. (2021) Rational Design of a Two‐Photon Fluorescent Probe for Human Cytochrome P450 3A and the Visualization of Mechanism‐Based Inactivation. Angewandte Chemie International Edition 61:5.
Crossref
Crossref
Jing Ning, Zhenhao Tian, Jiayue Wang, Bo Wang, Xiangge Tian, Zhenlong Yu, Xiaokui Huo, Lei Feng, Jingnan Cui, Tony D. James & Xiaochi Ma. (2021) Rational Design of a Two‐Photon Fluorescent Probe for Human Cytochrome P450 3A and the Visualization of Mechanism‐Based Inactivation. Angewandte Chemie 134:5.
Crossref
Crossref
Makiko Yamada, Shin-ichi Inoue, Daisuke Sugiyama, Yumi Nishiya, Tomoko Ishizuka, Akiko Watanabe, Kengo Watanabe, Shinji Yamashita & Nobuaki Watanabe. (2020) Critical Impact of Drug-Drug Interactions via Intestinal CYP3A in the Risk Assessment of Weak Perpetrators Using Physiologically Based Pharmacokinetic Models. Drug Metabolism and Disposition 48:4, pages 288-296.
Crossref
Crossref
Jaydeep Yadav, Erickson Paragas, Ken Korzekwa & Swati Nagar. (2020) Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions. Pharmacology & Therapeutics 206, pages 107449.
Crossref
Crossref
Luís Felipe José Ravic de Miranda, Karina Braga Gomes & Paulo Caramelli. 2020. Genetics, Neurology, Behavior, and Diet in Dementia. Genetics, Neurology, Behavior, and Diet in Dementia
89
102
.
Pengfei Chu, Libo He, Denghui Zhu, Rong Huang, Lanjie Liao, Yongming Li, Zuoyan Zhu & Yaping Wang. (2019) Identification, expression and functional characterisation of CYP1A in grass carp (Ctenopharyngodon idella). Fish & Shellfish Immunology 95, pages 35-43.
Crossref
Crossref
Jaydeep Yadav, Ken Korzekwa & Swati Nagar. (2018) Improved Predictions of Drug–Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A. Molecular Pharmaceutics 15:5, pages 1979-1995.
Crossref
Crossref
Xavier Boulenc, Olivier Nicolas, Stéphanie Hermabessière, Isabelle Zobouyan, Valérie Martin, Yves Donazzolo & Céline Ollier. (2014) CYP3A4-based drug–drug interaction: CYP3A4 substrates’ pharmacokinetic properties and ketoconazole dose regimen effect. European Journal of Drug Metabolism and Pharmacokinetics 41:1, pages 45-54.
Crossref
Crossref
Lili Wu, Wanping Zhong, Junjin Liu, Weichao Han, Shilong Zhong, Qiang Wei, Shuwen Liu & Lan Tang. (2015) Human microsomal cyttrochrome P450-mediated reduction of oxysophocarpine, an active and highly toxic constituent derived from Sophora flavescens species, and its intestinal absorption and metabolism in rat. Fitoterapia 105, pages 26-36.
Crossref
Crossref
Youngjae Kim, Jeeyeon Kim, Sora Kim, Yooran Ki, Seon Hee Seo, Jinsung Tae, Min Kyung Ko, Hyun-Seo Jang, Eun Jeong Lim, Chiman Song, YoonJeong Cho, Hae-Young Koh, Youhoon Chong, Il Han Choo, Gyochang Keum, Sun-Joon Min & Hyunah Choo. (2014) Novel thienopyrimidinones as mGluR1 antagonists. European Journal of Medicinal Chemistry 85, pages 629-637.
Crossref
Crossref
Andrew V. Stachulski, Thomas A. Baillie, B. Kevin Park, R. Scott Obach, Deepak K. Dalvie, Dominic P. Williams, Abhishek Srivastava, Sophie L. Regan, Daniel J. Antoine, Christopher E. P. Goldring, Alvin J. L. Chia, Neil R. Kitteringham, Laura E. Randle, Hayley Callan, J. Luis Castrejon, John Farrell, Dean J. Naisbitt & Martin S. Lennard. (2013) The Generation, Detection, and Effects of Reactive Drug Metabolites. Medicinal Research Reviews 33:5, pages 985-1080.
Crossref
Crossref
Takeshi Akiyoshi, Marie Ito, Saori Murase, Mitsue Miyazaki, F. Peter Guengerich, Katsunori Nakamura, Koujirou Yamamoto & Hisakazu Ohtani. (2013) Mechanism-based Inhibition Profiles of Erythromycin and Clarithromycin with Cytochrome P450 3A4 Genetic Variants. Drug Metabolism and Pharmacokinetics 28:5, pages 411-415.
Crossref
Crossref
Ming Yao, Hong Cai & Mingshe Zhu. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
213
232
.
Alexander V. LyubimovJames M. MKim. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
28
.
Assaf Gottlieb, Gideon Y Stein, Yoram Oron, Eytan Ruppin & Roded Sharan. (2012) INDI: a computational framework for inferring drug interactions and their associated recommendations. Molecular Systems Biology 8:1.
Crossref
Crossref
M. Abid Masood, Matthew D. Selby, Andrew S. Bell, Andrew C. Mansfield, Mark Gardner, Graham F. Smith, Charlotte Lane, Helen Kenyon-Edwards, Rachel Osborne, Rhys M. Jones, Wai L. Liu, Christopher D. Brown, Nicholas Clarke, Francesca Perrucio & Charles E. Mowbray. (2011) Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure–activity relationship (SAR). Bioorganic & Medicinal Chemistry Letters 21:21, pages 6591-6595.
Crossref
Crossref
Kaisa A. Salminen, Jukka Leppänen, Jarkko I. Venäläinen, Markku Pasanen, Seppo Auriola, Risto O. Juvonen & Hannu Raunio. (2011) Simple, Direct, and Informative Method for the Assessment of CYP2C19 Enzyme Inactivation Kinetics. Drug Metabolism and Disposition 39:3, pages 412-418.
Crossref
Crossref
V. Hafner, B. Grün, C. Markert, D. Czock, G. Mikus & W.E. Haefeli. (2010) ArzneimittelinteraktionenDrug interactions. Der Internist 51:3, pages 359-370.
Crossref
Crossref